FGFR4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | Y147 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| O00115 | Y53 | Sugiyama | DNASE2 DNASE2A DNL2 | YKLPALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEG |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00170 | Y202 | Sugiyama | AIP XAP2 | IHQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPE |
| O00170 | Y203 | Sugiyama | AIP XAP2 | HQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPEW |
| O00264 | Y180 | Sugiyama | PGRMC1 HPR6.6 PGRMC | FTFKYHHVGKLLKEGEEPtVysDEEEPKDEsARKND_____ |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O14602 | Y35 | Sugiyama | EIF1AY | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEALCFDGV |
| O14639 | Y383 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | sIPGsPGHtIyAKVDNEILDyKDLAAIPKVKAIYDIERPDL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43172 | Y31 | Sugiyama | PRPF4 PRP4 | ATKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGIL |
| O43172 | Y32 | Sugiyama | PRPF4 PRP4 | TKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGILG |
| O43252 | Y238 | Sugiyama | PAPSS1 ATPSK1 PAPSS | ELLQERDIVPVDAsYEVKELyVPENKLHLAKTDAETLPALK |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43448 | Y311 | Sugiyama | KCNAB3 KCNA3B | LITSKYDGRVPDTCRASIKGyQWLKDKVQSEDGKKQQAKVM |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43765 | T194 | Sugiyama | SGTA SGT SGT1 | KHVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTG |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60361 | Y37 | Sugiyama | NME2P1 | GFRLVAMKFLPASEEHLKQHyIDLKDRPFFPGLVKYMNSGP |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y134 | Sugiyama | ENDOD1 KIAA0830 | EAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQ |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95757 | Y30 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | FLNCYIAVARsGGIETIANEySDRCtPACIsLGSRTRAIGN |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| O95997 | Y111 | Sugiyama | PTTG1 EAP1 PTTG TUTR1 | KKMTEKTVKAKSSVPASDDAyPEIEKFFPFNPLDFESFDLP |
| O96019 | Y68 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DDGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPL |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04181 | Y48 | Sugiyama | OAT | VATKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGI |
| P04181 | Y50 | Sugiyama | OAT | TKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyL |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04406 | Y94 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ItIFQERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQG |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05067 | Y308 | Sugiyama | APP A4 AD1 | REVCSEQAETGPCRAMISRWyFDVTEGKCAPFFyGGCGGNR |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05997 | S1308 | Sugiyama | COL5A2 | SKKHPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYC |
| P05997 | Y1311 | Sugiyama | COL5A2 | HPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYCNME |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07205 | Y196 | Sugiyama | PGK2 PGKB | MVGVNLPHKASGFLMKKELDyFAKALENPVRPFLAILGGAK |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y147 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | Y36 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IGAKFWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAtG |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07711 | Y330 | Sugiyama | CTSL CTSL1 | GyVKMAKDRRNHCGIAsAAsyPtV_________________ |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08621 | Y146 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | yGPIKRIHMVYSKRsGKPRGyAFIEyEHERDMHSAYKHADG |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | S541 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EAEKYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGK |
| P11142 | Y134 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYPEEVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQ |
| P11142 | Y149 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIAEAyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNV |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11233 | Y153 | Sugiyama | RALA RAL | DKRQVsVEEAKNRAEQWNVNyVETSAKTRANVDKVFFDLMR |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12270 | Y140 | Sugiyama | TPR | LEAEKRDLIRTNERLsQELEyLTEDVKRLNEKLKESNTTKG |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14618 | Y148 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | GtAEVELKKGATLKITLDNAyMEKCDENILWLDYKNICKVV |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P14625 | Y429 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IKLYVRRVFITDDFHDMMPKyLNFVKGVVDsDDLPLNVsRE |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y34 | Sugiyama | COX6B1 COX6B | TAPFDSRFPNQNQTRNCWQNyLDFHRCQKAMTAKGGDIsVC |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P14927 | Y90 | Sugiyama | UQCRB UQBP | NLKHQILPKEQWTKyEEENFyLEPyLKEVIRERKEREEWAK |
| P15153 | Y154 | Sugiyama | RAC2 | LAPITYPQGLALAKEIDSVKyLECsALtQRGLKtVFDEAIR |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15328 | Y80 | Sugiyama | FOLR1 FOLR | WRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHF |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y372 | Sugiyama | NELFE RD RDBP | NsPKGCHRDKRTQIVysDDVyKENLVDGF____________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y433 | Sugiyama | NCL | FEDAAEIRLVSKDGKSKGIAyIEFKTEADAEKTFEEKQGtE |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | Y174 | Sugiyama | EIF2S2 EIF2B | DDGIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDM |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22059 | Y456 | Sugiyama | OSBP OSBP1 | MPVNFNEPLSMLQRLTEDLEyHELLDRAAKCENSLEQLCYV |
| P22059 | Y791 | Sugiyama | OSBP OSBP1 | WFERKKDPVTKELTHIyRGEyWECKEKQDWSsCPDIF____ |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y560 | Sugiyama | UBA1 A1S9T UBE1 | NPHIRVTSHQNRVGPDtERIyDDDFFQNLDGVANALDNVDA |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22392 | Y52 | Sugiyama | NME2 NM23B | GFRLVAMKFLRAsEEHLKQHyIDLKDRPFFPGLVKYMNSGP |
| P22455 | S573 | Sugiyama | FGFR4 JTK2 TKF | AAKGNLREFLRARRPPGPDLsPDGPRSSEGPLSFPVLVSCA |
| P22455 | Y602 | Sugiyama | FGFR4 JTK2 TKF | GPLSFPVLVSCAYQVARGMQyLESRKCIHRDLAARNVLVTE |
| P22455 | Y642 | GPS6|SIGNOR|EPSD|Sugiyama | FGFR4 JTK2 TKF | EDNVMKIADFGLARGVHHIDyyKKTSNGRLPVKWMAPEALF |
| P22455 | Y643 | GPS6|SIGNOR|EPSD|Sugiyama | FGFR4 JTK2 TKF | DNVMKIADFGLARGVHHIDyyKKTSNGRLPVKWMAPEALFD |
| P22455 | Y719 | Sugiyama | FGFR4 JTK2 TKF | FSLLREGHRMDRPPHCPPELyGLMRECWHAAPSQRPTFKQL |
| P22455 | Y754 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | FGFR4 JTK2 TKF | PTFKQLVEALDKVLLAVSEEyLDLRLTFGPYSPSGGDASST |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25208 | Y58 | Sugiyama | NFYB HAP3 | SMNDHEDTNGSKESFREQDIyLPIANVARIMKNAIPQTGKI |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P26639 | Y53 | Sugiyama | TARS1 TARS | KKNKEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILA |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28062 | Y184 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | GMGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGN |
| P28062 | Y185 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGNT |
| P28062 | Y271 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MKEDGWVKVEsTDVSDLLHQyREANQ_______________ |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28074 | Y171 | Sugiyama | PSMB5 LMPX MB1 X | GMGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGS |
| P28074 | Y236 | Sugiyama | PSMB5 LMPX MB1 X | RRAIyQATYRDAysGGAVNLyHVREDGWIRVSsDNVADLHE |
| P29144 | Y1042 | Sugiyama | TPP2 | TEALRDLKIQWMTKLDSsDIyNELKEtyPNyLPLyVARLHQ |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y265 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | PHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMM |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1031 | Sugiyama | CPS1 | VVVNCNPETVstDFDECDKLyFEELSLERILDIYHQEACGG |
| P31689 | Y52 | Sugiyama | DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4 | KYHPDKNPNEGEKFKQISQAyEVLSDAKKRELYDKGGEQAI |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31943 | Y82 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EsEDEVKLALKKDRETMGHRyVEVFKSNNVEMDWVLKHtGP |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y213 | Sugiyama | SFN HME1 | LAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNLtLWTAD |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32004 | Y310 | Sugiyama | L1CAM CAML1 MIC5 | YQNHNKTLQLLKVGEEDDGEyRCLAENSLGSARHAYYVTVE |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33316 | Y227 | Sugiyama | DUT | EKFEVKKGDRIAQLICERIFyPEIEEVQALDDtERGsGGFG |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P35579 | Y9 | Sugiyama | MYH9 | ____________MAQQAADKyLyVDKNFINNPLAQADWAAK |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35606 | Y824 | Sugiyama | COPB2 | AFVVEEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQP |
| P36871 | Y157 | Sugiyama | PGM1 | GPAPEAITDKIFQISKTIEEyAVCPDLKVDLGVLGKQQFDL |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40763 | Y705 | SIGNOR|EPSD | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42224 | Y701 | SIGNOR|iPTMNet|EPSD | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42765 | Y198 | Sugiyama | ACAA2 | ECDKyALQSQQRWKAANDAGyFNDEMAPIEVKTKKGKQTMQ |
| P43243 | S211 | Sugiyama | MATR3 KIAA0723 | DRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCR |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y214 | Sugiyama | MATR3 KIAA0723 | PsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDs |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47813 | Y35 | Sugiyama | EIF1AX EIF1A EIF4C | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEAMCFDGV |
| P47897 | Y748 | Sugiyama | QARS1 QARS | VDCSVALAKPFDKFQFERLGyFsVDPDsHQGKLVFNRTVTL |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49458 | Y18 | Sugiyama | SRP9 | ___MPQYQTWEEFSRAAEKLyLADPMKARVVLKYRHsDGNL |
| P49588 | Y667 | Sugiyama | AARS1 AARS | QQIKKAEEIANEMIEAAKAVyTQDCPLAAAKAIQGLRAVFD |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P50402 | Y94 | Sugiyama | EMD EDMD STA | yDLPKKEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPS |
| P50402 | Y99 | Sugiyama | EMD EDMD STA | KEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPSRAVRQ |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51151 | Y148 | Sugiyama | RAB9A RAB9 | ISERQVsTEEAQAWCRDNGDyPyFETSAKDATNVAAAFEEA |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52565 | Y144 | Sugiyama | ARHGDIA GDIA1 | SGMKYIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEE |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55196 | Y1230 | Sugiyama | AFDN AF6 MLLT4 | QtPPPRPEAyPIPtQtYtREyFtFPAsKsQDRMAPPQNQWP |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55263 | Y129 | Sugiyama | ADK | IDKFGEILKRKAAEAHVDAHyyEQNEQPTGTCAACITGDNR |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55795 | Y82 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EsEEEVKLALKKDRETMGHRyVEVFKSNsVEMDWVLKHtGP |
| P55809 | Y43 | Sugiyama | OXCT1 OXCT SCOT | TWYKGCVCSFSTSAHRHTKFyTDPVEAVKDIPDGATVLVGG |
| P55884 | Y768 | Sugiyama | EIF3B EIF3S9 | ERRRTMMEDFRKYRKMAQELyMEQKNERLELRGGVDTDELD |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60763 | Y154 | Sugiyama | RAC3 | LAPITYPQGLAMAREIGSVKyLECsALtQRGLKtVFDEAIR |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61024 | S9 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ____________MSHKQIyysDKyDDEEFEyRHVMLPKDIA |
| P61024 | Y19 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | __MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLVPKTHLMs |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y216 | Sugiyama | YWHAG | LAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWtsD |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62241 | Y113 | Sugiyama | RPS8 OK/SW-cl.83 | TKTLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEE |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62258 | Y131 | Sugiyama | YWHAE | AANtGEsKVFyyKMKGDYHRyLAEFAtGNDRKEAAENsLVA |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62333 | Y328 | Sugiyama | PSMC6 SUG2 | ARLDILKIHAGPITKHGEIDyEAIVKLSDGFNGADLRNVCT |
| P62714 | Y80 | Sugiyama | PPP2CB | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63000 | Y154 | Sugiyama | RAC1 TC25 MIG5 | LTPITYPQGLAMAKEIGAVKyLECsALtQRGLKtVFDEAIR |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y80 | Sugiyama | PPP2CA | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68104 | Y86 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00059 | Y165 | Sugiyama | TFAM TCF6 TCF6L2 | KKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQEKLKTV |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00534 | Y13 | Sugiyama | CDK6 CDKN6 | ________MEKDGLCRADQQyECVAEIGEGAyGKVFKARDL |
| Q00610 | S1483 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VNEsLNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHE |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q04760 | Y136 | SIGNOR|PSP | GLO1 | HNGNsDPRGFGHIGIAVPDVySACKRFEELGVKFVKKPDDG |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y20 | Sugiyama | YWHAH YWHA1 | _MGDREQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | Y1191 | Sugiyama | TJP1 ZO1 | LRPEAQPHPsAGPKPAEsKQyFEQysRsyEQVPPQGFTSRA |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07960 | Y65 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | DDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRKI |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q13043 | Y433 | GPS6|PSP | STK4 KRS2 MST1 | KsVPGPLKNSsDWKIPQDGDyEFLKsWtVEDLQKRLLALDP |
| Q13085 | Y2144 | Sugiyama | ACACA ACAC ACC1 ACCA | VEIKFRRKDLVKTMRRVDPVyIHLAERLGTPELSTAERKEL |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13228 | Y33 | Sugiyama | SELENBP1 SBP | STPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVDVDPKs |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13283 | T21 | Sugiyama | G3BP1 G3BP | MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssyV |
| Q13283 | Y20 | Sugiyama | G3BP1 G3BP | _MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssy |
| Q13303 | Y270 | Sugiyama | KCNAB2 KCNA2B KCNK2 | IVSGKYDSGIPPYSRAsLKGyQWLKDKILSEEGRRQQAKLK |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13573 | Y292 | Sugiyama | SNW1 SKIIP SKIP | GRGLQTVHINENFAKLAEALyIADRKAREAVEMRAQVERKM |
| Q13615 | Y1023 | Sugiyama | MTMR3 KIAA0371 ZFYVE10 | ATssPDQPSRSHLDDDGMSVyTDTIQQRLRQIESGHQQEVE |
| Q13642 | Y117 | Sugiyama | FHL1 SLIM1 | DsPKCKGCFKAIVAGDQNVEyKGtVWHKDCFTCSNCKQVIG |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14258 | Y245 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | NRQQDVRMTANRKVEQLQQEytEMKALLDASETTSTRKIKE |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14651 | Y463 | Sugiyama | PLS1 | VNKPPYPALGGNMKKIENCNyAVELGKNKAKFSLVGIAGQD |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15181 | Y17 | Sugiyama | PPA1 IOPPP PP | ____MSGFSTEERAAPFsLEyRVFLKNEKGQyIsPFHDIPI |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15424 | Y723 | Sugiyama | SAFB HAP HET SAFB1 | EQERRPAVRRPYDLDRRDDAyWPEAKRAALDERYHSDFNRQ |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15650 | Y289 | Sugiyama | TRIP4 RQT4 | LLEFDRtsIRRtQVIDDESDyFASDSNQWLSKLERETLQKR |
| Q15785 | Y25 | Sugiyama | TOMM34 URCC3 | FPDsVEELRAAGNESFRNGQyAEASALyGRALRVLQAQGss |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VTE0 | Y86 | Sugiyama | EEF1A1P5 EEF1AL3 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N7H5 | Y322 | Sugiyama | PAF1 PD2 | KASKGyEENyFFIFREGDGVyyNELETRVRLSKRRAKAGVQ |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8NDI1 | Y585 | Sugiyama | EHBP1 KIAA0903 NACSIN | TYKVGNYETDTNssVDQEKFyAELSDLKREPELQQPISGAV |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WUA2 | Y401 | Sugiyama | PPIL4 | TSKKHKKKTHHCsEEKEDEDyMPIKNTNQDIYREMGFGHYE |
| Q8WWM7 | S276 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | MFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRA |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96F86 | Y258 | Sugiyama | EDC3 LSM16 YJDC YJEFN2 PP844 | NERPTRYRHDENILESEPIVyRRIIVPHNVSKEFCTDSGLV |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HE7 | Y178 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | HDDSSDNFCEADDIQsPEAEyVDLLLNPERYTGYKGPDAWK |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99459 | Y511 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAERV |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99536 | Y240 | Sugiyama | VAT1 | TASASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIV |
| Q99536 | Y245 | Sugiyama | VAT1 | KHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDPLG |
| Q99543 | Y137 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | KHHPDKRKAAGEPIKEGDNDyFTCITKAYEMLSDPVKRRAF |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y432 | Sugiyama | ACO2 | SQFtITPGSEQIRAtIERDGyAQILRDLGGIVLANACGPCI |
| Q99832 | Y302 | Sugiyama | CCT7 CCTH NIP7-1 | HHSGAKVVLSKLPIGDVAtQyFADRDMFCAGRVPEEDLKRT |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BU89 | Y290 | Sugiyama | DOHH HLRC1 | RESCEVALDMyEHETGRAFQyADGLEQLRGAPS________ |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9GZT8 | Y175 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | PSKAPNyPTEGNHRVEFNVNytQDLDKVMSAVKGIDGVsVT |
| Q9H2U1 | Y169 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NQEKKMFRIRNRsyIDRDsEyLLQENEPDGtLDQKLLEDLQ |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H814 | T151 | Sugiyama | PHAX RNUXA | ATELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDL |
| Q9H814 | Y154 | Sugiyama | PHAX RNUXA | LGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLDKE |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9NQA5 | Y647 | Sugiyama | TRPV5 ECAC1 | DRWFLRVENHNDQNPLRVLRyVEVFKNsDKEDDQEHPSEKQ |
| Q9NRX4 | Y116 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AyGPAQHAISTEKIKAKyPDyEVtWANDGy___________ |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVS9 | Y195 | Sugiyama | PNPO | SSVIPDREYLRKKNEELEQLyQDQEVPKPKSWGGYVLYPQV |
| Q9NW64 | Y116 | Sugiyama | RBM22 ZC3H16 199G4 | VRDAGLSFKDDMPKSDVNKEyyTQNMEREISNsDGTRPVGM |
| Q9NWS0 | Y194 | Sugiyama | PIH1D1 NOP17 | IsQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWL |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NYU2 | Y1516 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | PMTKEPKLEAAVRIVPEWQDyDQEIKQLQIRFQKEKETGAL |
| Q9NZH5 | Y111 | Sugiyama | PTTG2 | KKMTEKTVKTKSSVPASDDAyPEIEKFFPFNLLDFESFDLP |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y352 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | TEEAREGIKQLLKQGSVQKVyNGLQGY______________ |
| Q9UHI6 | Y659 | Sugiyama | DDX20 DP103 GEMIN3 | RVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyLEGssD |
| Q9UHX1 | Y269 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | FGKIKSCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNL |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UKJ3 | Y90 | Sugiyama | GPATCH8 GPATC8 KIAA0553 | IPIVVKYDVMGMGRMEMELDyAEDATERRRVLEVEKEDTEE |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UMS0 | Y194 | Sugiyama | NFU1 HIRIP5 CGI-33 | KELLDTRIRPTVQEDGGDVIyKGFEDGIVQLKLQGSCTSCP |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UNN5 | Y515 | Sugiyama | FAF1 UBXD12 UBXN3A CGI-03 | IKDEDEREARENVKREQDEAyRLsLEADRAKREAHEREMAE |
| Q9UQ80 | Y343 | Sugiyama | PA2G4 EBP1 | VLLMPNGPMRITsGPFEPDLyKsEMEVQDAELKALLQssAs |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y394 | Y330 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | NKMGKKRIENFKSGVDADssyFKIFKTKHD___________ |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y5Q8 | Y393 | Sugiyama | GTF3C5 CDABP0017 | SGtsGARKPASSKYKLKDSVyIFREGALPPYRQMFYQLCDL |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.186340e-14 | 13.497 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.130030e-14 | 13.384 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.147971e-13 | 12.940 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.147971e-13 | 12.940 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.466605e-13 | 12.834 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.153833e-13 | 12.667 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.619016e-13 | 12.582 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.985079e-13 | 12.702 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.426948e-13 | 12.615 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.157474e-13 | 12.501 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.157474e-13 | 12.501 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.181411e-13 | 12.286 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.833423e-13 | 12.165 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.218692e-12 | 11.914 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.163514e-12 | 11.934 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.163514e-12 | 11.934 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.436073e-12 | 11.843 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.673217e-12 | 11.776 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.929679e-12 | 11.715 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.208012e-12 | 11.656 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.462586e-12 | 11.609 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.462586e-12 | 11.609 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.125056e-12 | 11.505 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.831380e-12 | 11.417 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.952039e-12 | 11.305 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.952039e-12 | 11.305 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.186607e-12 | 11.209 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.817058e-12 | 11.055 | 1 | 1 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.520496e-12 | 11.021 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.520496e-12 | 11.021 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.173162e-11 | 10.931 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.759193e-11 | 10.755 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.759193e-11 | 10.755 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.842415e-11 | 10.735 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.141431e-11 | 10.669 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.770351e-11 | 10.557 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.734535e-11 | 10.563 | 1 | 1 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.910816e-11 | 10.536 | 1 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.682965e-11 | 10.329 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.422807e-11 | 10.266 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.961498e-11 | 10.225 | 1 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.465639e-11 | 10.189 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.685497e-11 | 10.114 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.108525e-11 | 10.041 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.747861e-10 | 9.757 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.929517e-10 | 9.715 | 1 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.043818e-10 | 9.690 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.384042e-10 | 9.623 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.140098e-10 | 9.503 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.220969e-10 | 9.492 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.530040e-10 | 9.344 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.725884e-10 | 9.242 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.577547e-10 | 9.182 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.856449e-10 | 9.006 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.016121e-09 | 8.993 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.123763e-09 | 8.949 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.123763e-09 | 8.949 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.278978e-09 | 8.893 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.362122e-09 | 8.866 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.410152e-09 | 8.851 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.648236e-09 | 8.783 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.110245e-09 | 8.676 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.684959e-09 | 8.571 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.738169e-09 | 8.563 | 1 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.395927e-09 | 8.469 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.810977e-09 | 8.419 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.810977e-09 | 8.419 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.222808e-09 | 8.282 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.222808e-09 | 8.282 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.165907e-09 | 8.088 | 1 | 1 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.284964e-09 | 8.082 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.141446e-09 | 8.039 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.123850e-08 | 7.949 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.180737e-08 | 7.928 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.190514e-08 | 7.924 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.020934e-08 | 7.694 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.507940e-08 | 7.601 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.699387e-08 | 7.569 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.244294e-08 | 7.489 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.019279e-08 | 7.396 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.019279e-08 | 7.396 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.019279e-08 | 7.396 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.245798e-08 | 7.372 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.245798e-08 | 7.372 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.300851e-08 | 7.201 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.546339e-08 | 7.184 | 1 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.107324e-08 | 7.148 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.164319e-07 | 6.934 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.251585e-07 | 6.903 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.978318e-07 | 6.704 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.465782e-07 | 6.608 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.621140e-07 | 6.582 | 1 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.860130e-07 | 6.544 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.847147e-07 | 6.546 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.053656e-07 | 6.515 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.353013e-07 | 6.475 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.353013e-07 | 6.475 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.563825e-07 | 6.448 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.037922e-07 | 6.394 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.674909e-07 | 6.246 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.608209e-06 | 5.794 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.621515e-06 | 5.790 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.621515e-06 | 5.790 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.008257e-06 | 5.697 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.990695e-06 | 5.524 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.419844e-06 | 5.466 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.488043e-06 | 5.457 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.476472e-06 | 5.349 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.813247e-06 | 5.236 | 1 | 1 |
| Chromatin organization | R-HSA-4839726 | 6.424982e-06 | 5.192 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.495155e-06 | 5.187 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.682075e-06 | 5.175 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.782475e-06 | 5.169 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.119339e-06 | 5.148 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.468383e-06 | 5.127 | 1 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.137751e-05 | 4.944 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.141168e-05 | 4.943 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.395074e-05 | 4.855 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.670923e-05 | 4.777 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.720340e-05 | 4.764 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.920760e-05 | 4.717 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.720340e-05 | 4.764 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.032129e-05 | 4.692 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.376221e-05 | 4.624 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.831509e-05 | 4.417 | 1 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.902801e-05 | 4.409 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.441835e-05 | 4.264 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.149917e-05 | 4.211 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.485021e-05 | 4.188 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.473163e-05 | 4.126 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.553344e-05 | 4.122 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.188316e-05 | 4.087 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.188316e-05 | 4.087 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.131074e-04 | 3.947 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.409591e-04 | 3.851 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.709643e-04 | 3.767 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.752033e-04 | 3.756 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.752033e-04 | 3.756 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.761563e-04 | 3.754 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.314084e-04 | 3.636 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.230009e-04 | 3.652 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.932311e-04 | 3.714 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.385324e-04 | 3.622 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.385324e-04 | 3.622 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.672031e-04 | 3.573 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.033383e-04 | 3.518 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.685873e-04 | 3.433 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.199771e-04 | 3.377 | 1 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.419102e-04 | 3.355 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.419102e-04 | 3.355 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.661991e-04 | 3.331 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.036061e-04 | 3.298 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.501783e-04 | 3.259 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.929577e-04 | 3.227 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.760762e-04 | 3.170 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.443747e-04 | 3.128 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.461112e-04 | 3.127 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.192219e-04 | 3.087 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.520823e-04 | 3.070 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.914019e-04 | 3.004 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.914019e-04 | 3.004 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.174795e-03 | 2.930 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.187459e-03 | 2.925 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.322239e-03 | 2.879 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.322239e-03 | 2.879 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.386481e-03 | 2.858 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.463815e-03 | 2.835 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.463815e-03 | 2.835 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.463815e-03 | 2.835 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.623437e-03 | 2.790 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.701465e-03 | 2.769 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.751865e-03 | 2.756 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.804308e-03 | 2.744 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.823447e-03 | 2.739 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.839880e-03 | 2.735 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.336296e-03 | 2.631 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.336296e-03 | 2.631 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.440141e-03 | 2.613 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.516244e-03 | 2.599 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.556174e-03 | 2.592 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.556174e-03 | 2.592 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.556174e-03 | 2.592 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.636648e-03 | 2.579 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.673535e-03 | 2.573 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.027292e-03 | 2.519 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.042734e-03 | 2.517 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.232933e-03 | 2.490 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.239766e-03 | 2.489 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.315814e-03 | 2.479 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.941426e-03 | 2.404 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.550725e-03 | 2.342 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.619183e-03 | 2.335 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.685785e-03 | 2.329 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.851348e-03 | 2.314 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.851348e-03 | 2.314 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.867243e-03 | 2.313 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.867243e-03 | 2.313 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 4.879361e-03 | 2.312 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.002460e-03 | 2.301 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.110336e-03 | 2.292 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.110336e-03 | 2.292 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.141270e-03 | 2.212 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.141270e-03 | 2.212 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.141270e-03 | 2.212 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.141270e-03 | 2.212 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.700537e-03 | 2.174 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.137222e-03 | 2.289 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.638101e-03 | 2.178 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.317282e-03 | 2.199 | 1 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 6.141270e-03 | 2.212 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.141270e-03 | 2.212 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.731135e-03 | 2.242 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.396357e-03 | 2.194 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.706913e-03 | 2.244 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.258740e-03 | 2.139 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.311742e-03 | 2.136 | 1 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.664851e-03 | 2.115 | 1 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.664851e-03 | 2.115 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.460846e-03 | 2.073 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.460846e-03 | 2.073 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.460846e-03 | 2.073 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.040676e-03 | 2.044 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.529687e-03 | 2.021 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 9.745723e-03 | 2.011 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.006581e-02 | 1.997 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.016682e-02 | 1.993 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.044038e-02 | 1.981 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.044038e-02 | 1.981 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.044038e-02 | 1.981 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.044038e-02 | 1.981 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.044038e-02 | 1.981 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.044038e-02 | 1.981 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.044038e-02 | 1.981 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.044038e-02 | 1.981 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.044038e-02 | 1.981 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.044038e-02 | 1.981 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.044038e-02 | 1.981 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.044038e-02 | 1.981 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.044038e-02 | 1.981 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.044038e-02 | 1.981 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.044038e-02 | 1.981 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.044038e-02 | 1.981 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.044038e-02 | 1.981 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.044038e-02 | 1.981 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.044038e-02 | 1.981 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.044038e-02 | 1.981 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.044038e-02 | 1.981 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.044038e-02 | 1.981 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.044038e-02 | 1.981 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.044038e-02 | 1.981 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.044038e-02 | 1.981 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.044038e-02 | 1.981 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.044038e-02 | 1.981 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.044038e-02 | 1.981 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.044038e-02 | 1.981 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.044038e-02 | 1.981 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.044038e-02 | 1.981 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.082815e-02 | 1.965 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.089852e-02 | 1.963 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.100723e-02 | 1.958 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.151385e-02 | 1.939 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.206383e-02 | 1.919 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.227943e-02 | 1.911 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.230682e-02 | 1.910 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.255646e-02 | 1.901 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.734832e-02 | 1.761 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.909221e-02 | 1.719 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.909221e-02 | 1.719 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.531243e-02 | 1.815 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.407873e-02 | 1.851 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.531243e-02 | 1.815 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.567659e-02 | 1.805 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.909221e-02 | 1.719 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.789133e-02 | 1.747 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.808943e-02 | 1.743 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.734832e-02 | 1.761 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.909221e-02 | 1.719 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.700653e-02 | 1.769 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.880136e-02 | 1.726 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.688627e-02 | 1.772 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.571608e-02 | 1.804 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.295890e-02 | 1.887 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.330749e-02 | 1.876 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.908232e-02 | 1.719 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.973666e-02 | 1.705 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.973666e-02 | 1.705 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.973666e-02 | 1.705 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.973666e-02 | 1.705 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.069727e-02 | 1.684 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.077240e-02 | 1.683 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.090660e-02 | 1.680 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.278984e-02 | 1.642 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.278984e-02 | 1.642 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.278984e-02 | 1.642 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.373106e-02 | 1.625 | 1 | 1 |
| FCGR activation | R-HSA-2029481 | 2.392113e-02 | 1.621 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.474031e-02 | 1.607 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.474031e-02 | 1.607 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.474031e-02 | 1.607 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.600528e-02 | 1.585 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.779348e-02 | 1.556 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.883662e-02 | 1.540 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.883662e-02 | 1.540 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.048156e-02 | 1.516 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.058295e-02 | 1.515 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.097936e-02 | 1.509 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.097936e-02 | 1.509 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.097936e-02 | 1.509 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.099717e-02 | 1.509 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.099717e-02 | 1.509 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.099717e-02 | 1.509 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.099717e-02 | 1.509 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 3.169477e-02 | 1.499 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.169477e-02 | 1.499 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.318311e-02 | 1.479 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.380926e-02 | 1.471 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.544639e-02 | 1.450 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.548426e-02 | 1.450 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.776774e-02 | 1.423 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.813464e-02 | 1.419 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.900746e-02 | 1.409 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.949677e-02 | 1.403 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.014570e-02 | 1.396 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.060498e-02 | 1.391 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.060498e-02 | 1.391 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.088339e-02 | 1.388 | 1 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.111581e-02 | 1.386 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.111581e-02 | 1.386 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.111581e-02 | 1.386 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.111581e-02 | 1.386 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.111581e-02 | 1.386 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.224951e-02 | 1.374 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.229437e-02 | 1.374 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.257886e-02 | 1.371 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.468263e-02 | 1.350 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.506582e-02 | 1.346 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.506582e-02 | 1.346 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.663224e-02 | 1.331 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.019568e-02 | 1.299 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.112940e-02 | 1.291 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.112940e-02 | 1.291 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.112940e-02 | 1.291 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.112940e-02 | 1.291 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.112940e-02 | 1.291 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.126503e-02 | 1.290 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.250844e-02 | 1.280 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.283590e-02 | 1.277 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.283590e-02 | 1.277 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.283590e-02 | 1.277 | 1 | 1 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.283590e-02 | 1.277 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.502276e-02 | 1.259 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.552456e-02 | 1.256 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.826037e-02 | 1.235 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.103903e-02 | 1.214 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.103903e-02 | 1.214 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.084578e-02 | 1.150 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.084578e-02 | 1.150 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.055070e-02 | 1.094 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.055070e-02 | 1.094 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.055070e-02 | 1.094 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.055070e-02 | 1.094 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.055070e-02 | 1.094 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.055070e-02 | 1.094 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 8.055070e-02 | 1.094 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.015485e-02 | 1.045 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.015485e-02 | 1.045 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.965926e-02 | 1.001 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.965926e-02 | 1.001 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.965926e-02 | 1.001 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.090650e-01 | 0.962 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.090650e-01 | 0.962 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.183730e-01 | 0.927 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.183730e-01 | 0.927 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.673818e-02 | 1.176 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.673818e-02 | 1.176 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.965926e-02 | 1.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 1.036487e-01 | 0.984 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.113746e-02 | 1.091 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.541203e-02 | 1.123 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.313034e-02 | 1.031 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.103903e-02 | 1.214 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 8.055070e-02 | 1.094 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.090650e-01 | 0.962 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.794394e-02 | 1.056 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.965926e-02 | 1.001 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.965018e-02 | 1.157 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.015485e-02 | 1.045 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.559611e-02 | 1.122 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.313034e-02 | 1.031 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.260321e-02 | 1.139 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.103903e-02 | 1.214 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.965018e-02 | 1.157 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.055070e-02 | 1.094 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.965926e-02 | 1.001 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.183730e-01 | 0.927 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.386841e-02 | 1.195 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.432830e-02 | 1.025 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.103903e-02 | 1.214 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 7.084578e-02 | 1.150 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 8.055070e-02 | 1.094 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.055070e-02 | 1.094 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.230791e-02 | 1.205 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.432830e-02 | 1.025 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.313034e-02 | 1.031 | 1 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.629043e-02 | 1.179 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.111947e-02 | 1.040 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.079827e-01 | 0.967 | 1 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 8.055070e-02 | 1.094 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 9.965926e-02 | 1.001 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.090650e-01 | 0.962 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.607738e-02 | 1.065 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.526589e-02 | 1.185 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.559611e-02 | 1.122 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.055070e-02 | 1.094 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.055070e-02 | 1.094 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.015485e-02 | 1.045 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.090650e-01 | 0.962 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.183730e-01 | 0.927 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.036487e-01 | 0.984 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.449976e-02 | 1.128 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.183730e-01 | 0.927 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.041444e-01 | 0.982 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.905441e-02 | 1.050 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.967353e-02 | 1.047 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.275844e-01 | 0.894 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.275844e-01 | 0.894 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.275844e-01 | 0.894 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.275844e-01 | 0.894 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.275844e-01 | 0.894 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.275844e-01 | 0.894 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.283206e-01 | 0.892 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.350737e-01 | 0.869 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.367000e-01 | 0.864 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.367000e-01 | 0.864 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.367000e-01 | 0.864 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.367000e-01 | 0.864 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.425786e-01 | 0.846 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.445191e-01 | 0.840 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.445191e-01 | 0.840 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.457210e-01 | 0.836 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.457210e-01 | 0.836 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.457210e-01 | 0.836 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.530400e-01 | 0.815 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.546483e-01 | 0.811 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.546483e-01 | 0.811 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.546483e-01 | 0.811 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.546483e-01 | 0.811 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.546483e-01 | 0.811 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.546483e-01 | 0.811 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.546483e-01 | 0.811 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.546483e-01 | 0.811 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.546483e-01 | 0.811 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.546483e-01 | 0.811 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.548444e-01 | 0.810 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.603527e-01 | 0.795 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.634828e-01 | 0.787 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.634828e-01 | 0.787 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.634828e-01 | 0.787 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.634828e-01 | 0.787 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.634828e-01 | 0.787 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.722255e-01 | 0.764 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.722255e-01 | 0.764 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.722255e-01 | 0.764 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.722255e-01 | 0.764 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.722255e-01 | 0.764 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.722255e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.722255e-01 | 0.764 | 1 | 1 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.808774e-01 | 0.743 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.808774e-01 | 0.743 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.808774e-01 | 0.743 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.808774e-01 | 0.743 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.808774e-01 | 0.743 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.808774e-01 | 0.743 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.808774e-01 | 0.743 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.808774e-01 | 0.743 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.808774e-01 | 0.743 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.824621e-01 | 0.739 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.864067e-01 | 0.730 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.894394e-01 | 0.723 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.894394e-01 | 0.723 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.894394e-01 | 0.723 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.894394e-01 | 0.723 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.894394e-01 | 0.723 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.894394e-01 | 0.723 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.894394e-01 | 0.723 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.894394e-01 | 0.723 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.939594e-01 | 0.712 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.979125e-01 | 0.704 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.979125e-01 | 0.704 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.041042e-01 | 0.690 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.062975e-01 | 0.686 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.062975e-01 | 0.686 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 2.062975e-01 | 0.686 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.062975e-01 | 0.686 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.130008e-01 | 0.672 | 1 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.130008e-01 | 0.672 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.145953e-01 | 0.668 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.145953e-01 | 0.668 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.145953e-01 | 0.668 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.145953e-01 | 0.668 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.145953e-01 | 0.668 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.145953e-01 | 0.668 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.228069e-01 | 0.652 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.228069e-01 | 0.652 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.228069e-01 | 0.652 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.245117e-01 | 0.649 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.258369e-01 | 0.646 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.283597e-01 | 0.641 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.309331e-01 | 0.637 | 1 | 1 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.309331e-01 | 0.637 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.309331e-01 | 0.637 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.309331e-01 | 0.637 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.309331e-01 | 0.637 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.309331e-01 | 0.637 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.309331e-01 | 0.637 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.360690e-01 | 0.627 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.380437e-01 | 0.623 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.389749e-01 | 0.622 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.389749e-01 | 0.622 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.389749e-01 | 0.622 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.469331e-01 | 0.607 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.469331e-01 | 0.607 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.469331e-01 | 0.607 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.469331e-01 | 0.607 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.548085e-01 | 0.594 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.548085e-01 | 0.594 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.548085e-01 | 0.594 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.548085e-01 | 0.594 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.548085e-01 | 0.594 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.553970e-01 | 0.593 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.591978e-01 | 0.586 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.626021e-01 | 0.581 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.626021e-01 | 0.581 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.626021e-01 | 0.581 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.626021e-01 | 0.581 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.626021e-01 | 0.581 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.626021e-01 | 0.581 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.648258e-01 | 0.577 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.648258e-01 | 0.577 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.676456e-01 | 0.572 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.703146e-01 | 0.568 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.703146e-01 | 0.568 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.703146e-01 | 0.568 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.703146e-01 | 0.568 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.703146e-01 | 0.568 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.708849e-01 | 0.567 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.761257e-01 | 0.559 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.779470e-01 | 0.556 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.779470e-01 | 0.556 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.779470e-01 | 0.556 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.779470e-01 | 0.556 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.779470e-01 | 0.556 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.779470e-01 | 0.556 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.854999e-01 | 0.544 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.929744e-01 | 0.533 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 2.929744e-01 | 0.533 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.929744e-01 | 0.533 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.929744e-01 | 0.533 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 2.929744e-01 | 0.533 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.929744e-01 | 0.533 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.929744e-01 | 0.533 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.076908e-01 | 0.512 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.076908e-01 | 0.512 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.076908e-01 | 0.512 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.076908e-01 | 0.512 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.095165e-01 | 0.509 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.149345e-01 | 0.502 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.149345e-01 | 0.502 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.149345e-01 | 0.502 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.149345e-01 | 0.502 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.149345e-01 | 0.502 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.149345e-01 | 0.502 | 1 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.149345e-01 | 0.502 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.149345e-01 | 0.502 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.149345e-01 | 0.502 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.221027e-01 | 0.492 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.221027e-01 | 0.492 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.286971e-01 | 0.483 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.291965e-01 | 0.483 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.291965e-01 | 0.483 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.291965e-01 | 0.483 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.331276e-01 | 0.477 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.331276e-01 | 0.477 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.362164e-01 | 0.473 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.362164e-01 | 0.473 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.362164e-01 | 0.473 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.362164e-01 | 0.473 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.362164e-01 | 0.473 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.439394e-01 | 0.464 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.500379e-01 | 0.456 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.500379e-01 | 0.456 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.500379e-01 | 0.456 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.500379e-01 | 0.456 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.500379e-01 | 0.456 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.568410e-01 | 0.448 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.568410e-01 | 0.448 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.568410e-01 | 0.448 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.635733e-01 | 0.439 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.665898e-01 | 0.436 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.702355e-01 | 0.432 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.833527e-01 | 0.416 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.871849e-01 | 0.412 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.898091e-01 | 0.409 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.898091e-01 | 0.409 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.961982e-01 | 0.402 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.999810e-01 | 0.398 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.010539e-01 | 0.397 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.040746e-01 | 0.394 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.087778e-01 | 0.389 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.149695e-01 | 0.382 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.180488e-01 | 0.379 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.210967e-01 | 0.376 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.210967e-01 | 0.376 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.210967e-01 | 0.376 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.210967e-01 | 0.376 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.217858e-01 | 0.375 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.329318e-01 | 0.364 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.331605e-01 | 0.363 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.331605e-01 | 0.363 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.390983e-01 | 0.357 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.390983e-01 | 0.357 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.449743e-01 | 0.352 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.507891e-01 | 0.346 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.507891e-01 | 0.346 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.565433e-01 | 0.341 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.565433e-01 | 0.341 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.678726e-01 | 0.330 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.678726e-01 | 0.330 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.734489e-01 | 0.325 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.734489e-01 | 0.325 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.789671e-01 | 0.320 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.789671e-01 | 0.320 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.789671e-01 | 0.320 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.793207e-01 | 0.319 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.812434e-01 | 0.318 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.844278e-01 | 0.315 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.898316e-01 | 0.310 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.898316e-01 | 0.310 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.898316e-01 | 0.310 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.946870e-01 | 0.306 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.951791e-01 | 0.305 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.004709e-01 | 0.301 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.040218e-01 | 0.298 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.057075e-01 | 0.296 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.057075e-01 | 0.296 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.057075e-01 | 0.296 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.108895e-01 | 0.292 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.108895e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.108895e-01 | 0.292 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.144367e-01 | 0.289 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.160176e-01 | 0.287 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.160176e-01 | 0.287 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.210922e-01 | 0.283 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.210922e-01 | 0.283 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.210922e-01 | 0.283 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.210922e-01 | 0.283 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.241203e-01 | 0.281 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.261139e-01 | 0.279 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.261139e-01 | 0.279 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.310832e-01 | 0.275 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.310832e-01 | 0.275 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.360008e-01 | 0.271 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.408670e-01 | 0.267 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.430975e-01 | 0.265 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.456826e-01 | 0.263 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.493063e-01 | 0.260 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.504479e-01 | 0.259 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.504479e-01 | 0.259 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.523886e-01 | 0.258 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.585089e-01 | 0.253 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.598300e-01 | 0.252 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.644478e-01 | 0.248 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.644478e-01 | 0.248 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.644478e-01 | 0.248 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.644478e-01 | 0.248 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.690174e-01 | 0.245 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.735394e-01 | 0.241 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.735394e-01 | 0.241 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.824423e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.824423e-01 | 0.235 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.824423e-01 | 0.235 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.868242e-01 | 0.231 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.911060e-01 | 0.228 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.954514e-01 | 0.225 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.996976e-01 | 0.222 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.038995e-01 | 0.219 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.080576e-01 | 0.216 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.080576e-01 | 0.216 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.092821e-01 | 0.215 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.162439e-01 | 0.210 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.202731e-01 | 0.207 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.352866e-01 | 0.197 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.359738e-01 | 0.197 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.397970e-01 | 0.194 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.397970e-01 | 0.194 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.405404e-01 | 0.193 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.405404e-01 | 0.193 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.457350e-01 | 0.190 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.473242e-01 | 0.189 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.473242e-01 | 0.189 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.510289e-01 | 0.186 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.546949e-01 | 0.184 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.654649e-01 | 0.177 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.654649e-01 | 0.177 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.689802e-01 | 0.175 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.724587e-01 | 0.172 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.724587e-01 | 0.172 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.759009e-01 | 0.170 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.780687e-01 | 0.169 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.793071e-01 | 0.168 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.826778e-01 | 0.166 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.826778e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.826778e-01 | 0.166 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.826778e-01 | 0.166 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.925799e-01 | 0.160 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.925799e-01 | 0.160 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.958118e-01 | 0.158 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.958118e-01 | 0.158 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.990100e-01 | 0.156 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.012836e-01 | 0.154 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.021747e-01 | 0.154 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.021747e-01 | 0.154 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.084053e-01 | 0.150 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.114718e-01 | 0.148 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.145063e-01 | 0.146 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.145063e-01 | 0.146 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.145063e-01 | 0.146 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.145063e-01 | 0.146 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.175090e-01 | 0.144 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.175090e-01 | 0.144 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.175090e-01 | 0.144 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.175090e-01 | 0.144 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.204803e-01 | 0.142 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.234206e-01 | 0.141 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.234206e-01 | 0.141 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.263301e-01 | 0.139 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.292092e-01 | 0.137 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.292092e-01 | 0.137 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.320582e-01 | 0.135 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.355393e-01 | 0.133 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 7.357673e-01 | 0.133 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.376671e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.404276e-01 | 0.131 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.404276e-01 | 0.131 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.431592e-01 | 0.129 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.435666e-01 | 0.129 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.458623e-01 | 0.127 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.458623e-01 | 0.127 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.458623e-01 | 0.127 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.538030e-01 | 0.123 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.538030e-01 | 0.123 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.573855e-01 | 0.121 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.589592e-01 | 0.120 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.614969e-01 | 0.118 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.614969e-01 | 0.118 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.664930e-01 | 0.115 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.761751e-01 | 0.110 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.809854e-01 | 0.107 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.877182e-01 | 0.104 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.899549e-01 | 0.102 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.899549e-01 | 0.102 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.921680e-01 | 0.101 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.028910e-01 | 0.095 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.049687e-01 | 0.094 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.150349e-01 | 0.089 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.169853e-01 | 0.088 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.169853e-01 | 0.088 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.189152e-01 | 0.087 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.264348e-01 | 0.083 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.264348e-01 | 0.083 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.336438e-01 | 0.079 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.336438e-01 | 0.079 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.346848e-01 | 0.078 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.388545e-01 | 0.076 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.455506e-01 | 0.073 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.471809e-01 | 0.072 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.535330e-01 | 0.069 | 0 | 0 |
| Translation | R-HSA-72766 | 8.537696e-01 | 0.069 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.581241e-01 | 0.066 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.654603e-01 | 0.063 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.764215e-01 | 0.057 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.770234e-01 | 0.057 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.828166e-01 | 0.054 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.888826e-01 | 0.051 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.912207e-01 | 0.050 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.935098e-01 | 0.049 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.012921e-01 | 0.045 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.139250e-01 | 0.039 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.175146e-01 | 0.037 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.183886e-01 | 0.037 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.192533e-01 | 0.037 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.235973e-01 | 0.035 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.266371e-01 | 0.033 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.281845e-01 | 0.032 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.353902e-01 | 0.029 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.388657e-01 | 0.027 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.489898e-01 | 0.023 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.504256e-01 | 0.022 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.526362e-01 | 0.021 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.560964e-01 | 0.019 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.574380e-01 | 0.019 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.592202e-01 | 0.018 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.645158e-01 | 0.016 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.647409e-01 | 0.016 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.783291e-01 | 0.010 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.863505e-01 | 0.006 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.863505e-01 | 0.006 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.894603e-01 | 0.005 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.894603e-01 | 0.005 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.914822e-01 | 0.004 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.969963e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.985608e-01 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999374e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 1.000000e+00 | 0.000 | 1 | 1 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 1.000000e+00 | 0.000 | 1 | 1 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 1.000000e+00 | 0.000 | 1 | 1 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 1.000000e+00 | 0.000 | 1 | 1 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 1.000000e+00 | 0.000 | 1 | 1 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.328271e-15 | 14.199 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.487699e-14 | 13.827 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.487699e-14 | 13.827 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.175238e-14 | 13.498 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.815171e-14 | 13.055 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.815171e-14 | 13.055 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.655343e-13 | 12.781 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.983480e-13 | 12.400 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.253575e-13 | 12.280 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.949508e-13 | 12.048 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.949508e-13 | 12.048 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.331601e-12 | 11.876 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.484923e-12 | 11.828 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.966427e-12 | 11.706 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.895595e-12 | 11.722 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.895595e-12 | 11.722 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.199130e-12 | 11.658 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.199130e-12 | 11.658 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.405964e-12 | 11.619 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.885803e-12 | 11.540 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.885803e-12 | 11.540 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.814282e-12 | 11.419 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.814282e-12 | 11.419 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.814282e-12 | 11.419 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.766298e-12 | 11.322 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.766298e-12 | 11.322 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.078027e-12 | 11.216 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.338241e-12 | 11.134 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.338241e-12 | 11.134 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.044543e-12 | 11.044 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.994228e-12 | 11.000 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.356859e-11 | 10.867 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.356859e-11 | 10.867 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.379652e-11 | 10.860 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.394307e-11 | 10.856 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.652067e-11 | 10.782 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.421874e-11 | 10.616 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.886280e-11 | 10.410 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.949641e-11 | 10.403 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.188305e-11 | 10.378 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.188305e-11 | 10.378 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.994871e-11 | 10.301 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.486078e-11 | 10.261 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.324219e-11 | 10.199 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.034628e-11 | 10.153 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.039758e-11 | 10.152 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.173073e-11 | 10.144 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.321277e-11 | 10.080 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.352105e-10 | 9.869 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.581409e-10 | 9.801 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.945294e-10 | 9.711 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.845075e-10 | 9.734 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.493927e-10 | 9.603 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.493927e-10 | 9.603 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.437127e-10 | 9.464 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.437445e-10 | 9.353 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.585273e-10 | 9.339 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.098622e-10 | 9.293 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.500753e-10 | 9.260 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.645470e-10 | 9.117 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.334937e-10 | 9.135 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.645470e-10 | 9.117 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.718797e-10 | 9.060 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.623096e-10 | 9.017 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.127934e-09 | 8.948 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.570664e-09 | 8.804 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.570664e-09 | 8.804 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.570664e-09 | 8.804 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.583422e-09 | 8.800 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.639103e-09 | 8.785 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.881267e-09 | 8.726 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.086448e-09 | 8.681 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.219973e-09 | 8.654 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.640126e-09 | 8.578 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.963471e-09 | 8.528 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.963471e-09 | 8.528 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.986400e-09 | 8.525 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.321801e-09 | 8.479 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.156839e-09 | 8.381 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.356265e-09 | 8.271 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.926057e-09 | 8.049 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.697575e-09 | 8.013 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.758997e-09 | 8.058 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.307557e-08 | 7.884 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.108112e-08 | 7.676 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.319539e-08 | 7.479 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.313630e-08 | 7.365 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.313630e-08 | 7.365 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.838735e-08 | 7.315 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.567933e-08 | 7.183 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.829281e-08 | 7.106 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.491870e-08 | 7.071 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.646660e-08 | 7.063 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.069609e-08 | 7.042 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.814129e-08 | 7.008 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.146781e-07 | 6.941 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.152782e-07 | 6.938 | 1 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.190384e-07 | 6.924 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.315868e-07 | 6.881 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.553368e-07 | 6.809 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.937430e-07 | 6.713 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.180013e-07 | 6.662 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.238086e-07 | 6.650 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.493947e-07 | 6.603 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.535236e-07 | 6.596 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.766645e-07 | 6.558 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.766645e-07 | 6.558 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.766645e-07 | 6.558 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.461441e-07 | 6.461 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.104378e-07 | 6.387 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.241339e-07 | 6.372 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.315559e-07 | 6.365 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.036721e-07 | 6.219 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.194375e-07 | 6.086 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.648134e-07 | 6.063 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.100375e-06 | 5.958 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.210277e-06 | 5.917 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.456962e-06 | 5.837 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.893768e-06 | 5.723 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.904062e-06 | 5.720 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.904062e-06 | 5.720 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.012506e-06 | 5.696 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.211117e-06 | 5.655 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.265967e-06 | 5.645 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.752538e-06 | 5.560 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.371072e-06 | 5.625 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.676182e-06 | 5.572 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.787609e-06 | 5.555 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.855296e-06 | 5.414 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.366274e-06 | 5.360 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.946354e-06 | 5.306 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.145448e-06 | 5.289 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.521826e-06 | 5.258 | 1 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.811811e-06 | 5.236 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.251195e-06 | 5.204 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.517683e-06 | 5.186 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.216181e-06 | 5.142 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.902283e-06 | 5.102 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.024451e-05 | 4.990 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.083302e-05 | 4.965 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.115525e-05 | 4.953 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.460171e-05 | 4.836 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.546958e-05 | 4.811 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.569324e-05 | 4.804 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.240962e-05 | 4.650 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.430419e-05 | 4.614 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.552308e-05 | 4.593 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.833568e-05 | 4.548 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.963247e-05 | 4.528 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.958897e-05 | 4.305 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.101135e-05 | 4.149 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.270708e-05 | 4.082 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.031505e-04 | 3.987 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.031505e-04 | 3.987 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.141185e-04 | 3.943 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.199763e-04 | 3.921 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.489785e-04 | 3.827 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.588526e-04 | 3.799 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.670102e-04 | 3.777 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.910353e-04 | 3.719 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.984087e-04 | 3.702 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.434981e-04 | 3.614 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.522127e-04 | 3.598 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.539988e-04 | 3.595 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.605747e-04 | 3.584 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.605747e-04 | 3.584 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.605747e-04 | 3.584 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.605747e-04 | 3.584 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.507533e-04 | 3.455 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.777184e-04 | 3.423 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.279366e-04 | 3.369 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.601984e-04 | 3.337 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.029210e-04 | 3.299 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.119424e-04 | 3.291 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.024444e-04 | 3.220 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.612051e-04 | 3.118 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.761052e-04 | 3.057 | 1 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.910057e-04 | 3.050 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.910057e-04 | 3.050 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.968547e-04 | 3.047 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.866983e-04 | 3.006 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.007198e-03 | 2.997 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.046927e-03 | 2.980 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.046927e-03 | 2.980 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.069341e-03 | 2.971 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.143398e-03 | 2.942 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.169873e-03 | 2.932 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.587100e-03 | 2.799 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.420290e-03 | 2.848 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.521702e-03 | 2.818 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.373605e-03 | 2.862 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.423607e-03 | 2.847 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.605418e-03 | 2.794 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.613541e-03 | 2.792 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.729752e-03 | 2.762 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.763994e-03 | 2.754 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.948391e-03 | 2.710 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.247950e-03 | 2.648 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.280424e-03 | 2.642 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.518877e-03 | 2.599 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.743217e-03 | 2.562 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.872156e-03 | 2.542 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.432018e-03 | 2.464 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.454994e-03 | 2.462 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.509904e-03 | 2.455 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.536180e-03 | 2.451 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.566303e-03 | 2.448 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.115667e-03 | 2.386 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.115667e-03 | 2.386 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.157925e-03 | 2.381 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.878592e-03 | 2.312 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.878592e-03 | 2.312 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.941719e-03 | 2.306 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.941719e-03 | 2.306 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.793135e-03 | 2.237 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.793135e-03 | 2.237 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.863729e-03 | 2.232 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.101245e-03 | 2.215 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.701023e-03 | 2.174 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.931822e-03 | 2.159 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.931822e-03 | 2.159 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.948404e-03 | 2.158 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.081098e-03 | 2.093 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.825138e-03 | 2.054 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.931622e-03 | 2.049 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.309812e-03 | 2.031 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.601423e-03 | 2.018 | 1 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.637927e-03 | 2.016 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.003935e-02 | 1.998 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.005024e-02 | 1.998 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.019454e-02 | 1.992 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.019454e-02 | 1.992 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.019454e-02 | 1.992 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.019454e-02 | 1.992 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.019454e-02 | 1.992 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.019454e-02 | 1.992 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.070023e-02 | 1.971 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.146506e-02 | 1.941 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.199870e-02 | 1.921 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.215644e-02 | 1.915 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.228318e-02 | 1.911 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.325832e-02 | 1.878 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.825585e-02 | 1.739 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.498506e-02 | 1.824 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.999395e-02 | 1.699 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.493147e-02 | 1.826 | 1 | 1 |
| Platelet degranulation | R-HSA-114608 | 1.604810e-02 | 1.795 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.683805e-02 | 1.774 | 1 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.929937e-02 | 1.714 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.498506e-02 | 1.824 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.970191e-02 | 1.705 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.515777e-02 | 1.819 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.054458e-02 | 1.687 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.179846e-02 | 1.662 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.179846e-02 | 1.662 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.179846e-02 | 1.662 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.230278e-02 | 1.652 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.275771e-02 | 1.643 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.321886e-02 | 1.634 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.351335e-02 | 1.629 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.351335e-02 | 1.629 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.351335e-02 | 1.629 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.559682e-02 | 1.592 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.560065e-02 | 1.592 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.560065e-02 | 1.592 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.560065e-02 | 1.592 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 2.658113e-02 | 1.575 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.759537e-02 | 1.559 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.759537e-02 | 1.559 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.868453e-02 | 1.542 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.868453e-02 | 1.542 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.871111e-02 | 1.542 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.965056e-02 | 1.528 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.021640e-02 | 1.520 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.027473e-02 | 1.519 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.223045e-02 | 1.492 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.292349e-02 | 1.482 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.292349e-02 | 1.482 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.379530e-02 | 1.471 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.393671e-02 | 1.469 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.393671e-02 | 1.469 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.535443e-02 | 1.452 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.579254e-02 | 1.446 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.592370e-02 | 1.445 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.616488e-02 | 1.442 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.631205e-02 | 1.440 | 1 | 0 |
| Innate Immune System | R-HSA-168249 | 3.635838e-02 | 1.439 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.016246e-02 | 1.396 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.016246e-02 | 1.396 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.016246e-02 | 1.396 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.016246e-02 | 1.396 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.016246e-02 | 1.396 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.016246e-02 | 1.396 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.078464e-02 | 1.390 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.317356e-02 | 1.365 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.401171e-02 | 1.356 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.460932e-02 | 1.351 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.561346e-02 | 1.341 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.810305e-02 | 1.318 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.986461e-02 | 1.302 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.994998e-02 | 1.301 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.994998e-02 | 1.301 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.994998e-02 | 1.301 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.994998e-02 | 1.301 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.292634e-02 | 1.276 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.322632e-02 | 1.274 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.322632e-02 | 1.274 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.585756e-02 | 1.253 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.922840e-02 | 1.160 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.872129e-02 | 1.104 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.741933e-02 | 1.011 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.741933e-02 | 1.011 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.741933e-02 | 1.011 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.066264e-01 | 0.972 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.066264e-01 | 0.972 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.157401e-01 | 0.937 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.401541e-02 | 1.194 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.681888e-02 | 1.175 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.157401e-01 | 0.937 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.125327e-02 | 1.213 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.066264e-01 | 0.972 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.032956e-01 | 0.986 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.741933e-02 | 1.011 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.157401e-01 | 0.937 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.373170e-02 | 1.028 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.820603e-02 | 1.055 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.872129e-02 | 1.104 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.877346e-02 | 1.231 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.032956e-01 | 0.986 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 7.872129e-02 | 1.104 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.157401e-01 | 0.937 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.842405e-02 | 1.106 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.157401e-01 | 0.937 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.254539e-02 | 1.139 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.963829e-02 | 1.224 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.066264e-01 | 0.972 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.157401e-01 | 0.937 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.239939e-02 | 1.140 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.483241e-02 | 1.071 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.337270e-02 | 1.079 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.922840e-02 | 1.160 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.049224e-01 | 0.979 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.098138e-01 | 0.959 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 1.065411e-01 | 0.972 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.022693e-01 | 0.990 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.872129e-02 | 1.104 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.872129e-02 | 1.104 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.811794e-02 | 1.055 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.157401e-01 | 0.937 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.000782e-01 | 1.000 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.842405e-02 | 1.106 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.065510e-01 | 0.972 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.157401e-01 | 0.937 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.125327e-02 | 1.213 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.164376e-01 | 0.934 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.096610e-02 | 1.215 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.017820e-02 | 1.045 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.114365e-01 | 0.953 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.131446e-02 | 1.147 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.125327e-02 | 1.213 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.842405e-02 | 1.106 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 1.065411e-01 | 0.972 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 1.065411e-01 | 0.972 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.087315e-01 | 0.964 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.003112e-01 | 0.999 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.688998e-02 | 1.014 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.688998e-02 | 1.014 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.431771e-02 | 1.074 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.131130e-01 | 0.946 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.688998e-02 | 1.014 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.688998e-02 | 1.014 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.230761e-01 | 0.910 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 1.231600e-01 | 0.910 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.240950e-01 | 0.906 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.240950e-01 | 0.906 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.247614e-01 | 0.904 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.247614e-01 | 0.904 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.247614e-01 | 0.904 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.247614e-01 | 0.904 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.247614e-01 | 0.904 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.336913e-01 | 0.874 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.336913e-01 | 0.874 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.336913e-01 | 0.874 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.336913e-01 | 0.874 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.355234e-01 | 0.868 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.403541e-01 | 0.853 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.425305e-01 | 0.846 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.425305e-01 | 0.846 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.438532e-01 | 0.842 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.438532e-01 | 0.842 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.512801e-01 | 0.820 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.512801e-01 | 0.820 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.512801e-01 | 0.820 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.512801e-01 | 0.820 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.512801e-01 | 0.820 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.512801e-01 | 0.820 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.512801e-01 | 0.820 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.512801e-01 | 0.820 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.521010e-01 | 0.818 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.544574e-01 | 0.811 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.544574e-01 | 0.811 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.580254e-01 | 0.801 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.599410e-01 | 0.796 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.599410e-01 | 0.796 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.599410e-01 | 0.796 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.599410e-01 | 0.796 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.616089e-01 | 0.792 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.685140e-01 | 0.773 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.685140e-01 | 0.773 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.685140e-01 | 0.773 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.685140e-01 | 0.773 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.688196e-01 | 0.773 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.691154e-01 | 0.772 | 1 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.768161e-01 | 0.752 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.770001e-01 | 0.752 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.770001e-01 | 0.752 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.770001e-01 | 0.752 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.770001e-01 | 0.752 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.770001e-01 | 0.752 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.770001e-01 | 0.752 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.770001e-01 | 0.752 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.770001e-01 | 0.752 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.770001e-01 | 0.752 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.797351e-01 | 0.745 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.833976e-01 | 0.737 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.854000e-01 | 0.732 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.854000e-01 | 0.732 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.870710e-01 | 0.728 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.937148e-01 | 0.713 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 1.937148e-01 | 0.713 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 1.937148e-01 | 0.713 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.937148e-01 | 0.713 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.937148e-01 | 0.713 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.937148e-01 | 0.713 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.937148e-01 | 0.713 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 1.944484e-01 | 0.711 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 1.944484e-01 | 0.711 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.945128e-01 | 0.711 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.983388e-01 | 0.703 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.018625e-01 | 0.695 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.019452e-01 | 0.695 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.019452e-01 | 0.695 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.019452e-01 | 0.695 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.100920e-01 | 0.678 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.100920e-01 | 0.678 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.100920e-01 | 0.678 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.100920e-01 | 0.678 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.157349e-01 | 0.666 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.181562e-01 | 0.661 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.181562e-01 | 0.661 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.205297e-01 | 0.657 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.205297e-01 | 0.657 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.261386e-01 | 0.646 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.261386e-01 | 0.646 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.261386e-01 | 0.646 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.261386e-01 | 0.646 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.261386e-01 | 0.646 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.280383e-01 | 0.642 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.340400e-01 | 0.631 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.340400e-01 | 0.631 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.340400e-01 | 0.631 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.340400e-01 | 0.631 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.355648e-01 | 0.628 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 2.398946e-01 | 0.620 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.418611e-01 | 0.616 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.418611e-01 | 0.616 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.418611e-01 | 0.616 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.418611e-01 | 0.616 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.418611e-01 | 0.616 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.418611e-01 | 0.616 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.418611e-01 | 0.616 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.496029e-01 | 0.603 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.496029e-01 | 0.603 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.506561e-01 | 0.601 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.506561e-01 | 0.601 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.572661e-01 | 0.590 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.572661e-01 | 0.590 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.572661e-01 | 0.590 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.572661e-01 | 0.590 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.572661e-01 | 0.590 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.572661e-01 | 0.590 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.572661e-01 | 0.590 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.619944e-01 | 0.582 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.648516e-01 | 0.577 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.648516e-01 | 0.577 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.648516e-01 | 0.577 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.648516e-01 | 0.577 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.648516e-01 | 0.577 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.695563e-01 | 0.569 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.699938e-01 | 0.569 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.706219e-01 | 0.568 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.723600e-01 | 0.565 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.723600e-01 | 0.565 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.723600e-01 | 0.565 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.723600e-01 | 0.565 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.723600e-01 | 0.565 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.723600e-01 | 0.565 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.723600e-01 | 0.565 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.755162e-01 | 0.560 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.797922e-01 | 0.553 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.797922e-01 | 0.553 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.797922e-01 | 0.553 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.800385e-01 | 0.553 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.808958e-01 | 0.551 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.871489e-01 | 0.542 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.871489e-01 | 0.542 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.871489e-01 | 0.542 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.871489e-01 | 0.542 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.871489e-01 | 0.542 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 2.884489e-01 | 0.540 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.922224e-01 | 0.534 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.944309e-01 | 0.531 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.944309e-01 | 0.531 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.944309e-01 | 0.531 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.944309e-01 | 0.531 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.944309e-01 | 0.531 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.997615e-01 | 0.523 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.016390e-01 | 0.521 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.016390e-01 | 0.521 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.016390e-01 | 0.521 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.016390e-01 | 0.521 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.016390e-01 | 0.521 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.087739e-01 | 0.510 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.087739e-01 | 0.510 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.087739e-01 | 0.510 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.087739e-01 | 0.510 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.087739e-01 | 0.510 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.144265e-01 | 0.502 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.144265e-01 | 0.502 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.147990e-01 | 0.502 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.158363e-01 | 0.501 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.158363e-01 | 0.501 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.158363e-01 | 0.501 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.158363e-01 | 0.501 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.158363e-01 | 0.501 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.158363e-01 | 0.501 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.158363e-01 | 0.501 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.222923e-01 | 0.492 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.228271e-01 | 0.491 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.228271e-01 | 0.491 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.297468e-01 | 0.482 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.297468e-01 | 0.482 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.297468e-01 | 0.482 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.297468e-01 | 0.482 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.297468e-01 | 0.482 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.297468e-01 | 0.482 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.297655e-01 | 0.482 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.365962e-01 | 0.473 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.365962e-01 | 0.473 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.365962e-01 | 0.473 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.409328e-01 | 0.467 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.433760e-01 | 0.464 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.433760e-01 | 0.464 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.433760e-01 | 0.464 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.500870e-01 | 0.456 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.500870e-01 | 0.456 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.500870e-01 | 0.456 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.520425e-01 | 0.453 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.557318e-01 | 0.449 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.567298e-01 | 0.448 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.567298e-01 | 0.448 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.567298e-01 | 0.448 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.567298e-01 | 0.448 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.567298e-01 | 0.448 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.567298e-01 | 0.448 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.633051e-01 | 0.440 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.633051e-01 | 0.440 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.633051e-01 | 0.440 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.698136e-01 | 0.432 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.762560e-01 | 0.425 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.762560e-01 | 0.425 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.762560e-01 | 0.425 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.762560e-01 | 0.425 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.762560e-01 | 0.425 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.762560e-01 | 0.425 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.813374e-01 | 0.419 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.813374e-01 | 0.419 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.826329e-01 | 0.417 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.826329e-01 | 0.417 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.826329e-01 | 0.417 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.826329e-01 | 0.417 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.826329e-01 | 0.417 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.826329e-01 | 0.417 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.826329e-01 | 0.417 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.826329e-01 | 0.417 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.826329e-01 | 0.417 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.826329e-01 | 0.417 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.826329e-01 | 0.417 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.885763e-01 | 0.411 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.889450e-01 | 0.410 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.889450e-01 | 0.410 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.889450e-01 | 0.410 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.889450e-01 | 0.410 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.921819e-01 | 0.407 | 1 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.951930e-01 | 0.403 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 3.977547e-01 | 0.400 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.013774e-01 | 0.396 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.013774e-01 | 0.396 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.029413e-01 | 0.395 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.029413e-01 | 0.395 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.041275e-01 | 0.393 | 1 | 1 |
| Netrin-1 signaling | R-HSA-373752 | 4.135584e-01 | 0.383 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.135584e-01 | 0.383 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.135584e-01 | 0.383 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.135584e-01 | 0.383 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.136106e-01 | 0.383 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.195561e-01 | 0.377 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.195561e-01 | 0.377 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.195561e-01 | 0.377 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.195561e-01 | 0.377 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.254929e-01 | 0.371 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.254929e-01 | 0.371 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.254929e-01 | 0.371 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.358373e-01 | 0.361 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.371861e-01 | 0.359 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.371861e-01 | 0.359 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.381317e-01 | 0.358 | 1 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.385256e-01 | 0.358 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.429436e-01 | 0.354 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.450363e-01 | 0.352 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.486426e-01 | 0.348 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 4.542837e-01 | 0.343 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.598673e-01 | 0.337 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.598673e-01 | 0.337 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.598673e-01 | 0.337 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.653942e-01 | 0.332 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.653942e-01 | 0.332 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.653942e-01 | 0.332 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.653942e-01 | 0.332 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.708649e-01 | 0.327 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.816399e-01 | 0.317 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.821483e-01 | 0.317 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.921967e-01 | 0.308 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.921967e-01 | 0.308 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 4.973948e-01 | 0.303 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.973948e-01 | 0.303 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.973948e-01 | 0.303 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.025399e-01 | 0.299 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.049630e-01 | 0.297 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.076327e-01 | 0.294 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.076327e-01 | 0.294 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.076327e-01 | 0.294 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.126736e-01 | 0.290 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.126736e-01 | 0.290 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.126736e-01 | 0.290 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.126736e-01 | 0.290 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.145413e-01 | 0.289 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.176632e-01 | 0.286 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.176632e-01 | 0.286 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.208591e-01 | 0.283 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.208591e-01 | 0.283 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.226021e-01 | 0.282 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.226021e-01 | 0.282 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.239975e-01 | 0.281 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.302332e-01 | 0.276 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.371191e-01 | 0.270 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.418599e-01 | 0.266 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.511973e-01 | 0.259 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.511973e-01 | 0.259 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.511973e-01 | 0.259 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.557948e-01 | 0.255 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.557948e-01 | 0.255 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.576049e-01 | 0.254 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.603455e-01 | 0.252 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.648498e-01 | 0.248 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.693083e-01 | 0.245 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 5.712126e-01 | 0.243 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.737213e-01 | 0.241 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.780894e-01 | 0.238 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.781045e-01 | 0.238 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.809761e-01 | 0.236 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.866926e-01 | 0.232 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.951215e-01 | 0.225 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.951215e-01 | 0.225 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.951215e-01 | 0.225 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 5.992716e-01 | 0.222 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.992716e-01 | 0.222 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.034350e-01 | 0.219 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.074454e-01 | 0.216 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.114699e-01 | 0.214 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.193964e-01 | 0.208 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.193964e-01 | 0.208 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.232991e-01 | 0.205 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.271621e-01 | 0.203 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.271621e-01 | 0.203 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.276083e-01 | 0.202 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.309857e-01 | 0.200 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.385163e-01 | 0.195 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.531224e-01 | 0.185 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.566813e-01 | 0.183 | 1 | 1 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.629282e-01 | 0.179 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.671417e-01 | 0.176 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.739387e-01 | 0.171 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.739387e-01 | 0.171 | 1 | 0 |
| Translation | R-HSA-72766 | 6.797845e-01 | 0.168 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.805977e-01 | 0.167 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 6.822685e-01 | 0.166 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.871215e-01 | 0.163 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.935129e-01 | 0.159 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.997745e-01 | 0.155 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.089292e-01 | 0.149 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.089292e-01 | 0.149 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.089292e-01 | 0.149 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.207053e-01 | 0.142 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.207053e-01 | 0.142 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.207053e-01 | 0.142 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.254882e-01 | 0.139 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.315776e-01 | 0.136 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.374873e-01 | 0.132 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.374873e-01 | 0.132 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 7.556944e-01 | 0.122 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.558033e-01 | 0.122 | 1 | 1 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.704879e-01 | 0.113 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.820522e-01 | 0.107 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.930371e-01 | 0.101 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.930371e-01 | 0.101 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.993620e-01 | 0.097 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.190896e-01 | 0.087 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.227973e-01 | 0.085 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.264295e-01 | 0.083 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.351765e-01 | 0.078 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.368880e-01 | 0.077 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.385691e-01 | 0.076 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.402331e-01 | 0.076 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.514127e-01 | 0.070 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.574483e-01 | 0.067 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.589187e-01 | 0.066 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.646511e-01 | 0.063 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.684573e-01 | 0.061 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.687980e-01 | 0.061 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.767166e-01 | 0.057 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.829512e-01 | 0.054 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.864886e-01 | 0.052 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 8.877124e-01 | 0.052 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.987899e-01 | 0.046 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.087806e-01 | 0.042 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.142978e-01 | 0.039 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.289370e-01 | 0.032 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.311226e-01 | 0.031 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.353746e-01 | 0.029 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.366297e-01 | 0.028 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.431906e-01 | 0.025 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.469215e-01 | 0.024 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.490908e-01 | 0.023 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.541360e-01 | 0.020 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.619525e-01 | 0.017 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.766718e-01 | 0.010 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.865405e-01 | 0.006 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.869586e-01 | 0.006 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.904910e-01 | 0.004 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.906806e-01 | 0.004 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.982187e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.982910e-01 | 0.001 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999147e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999984e-01 | 0.000 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.000000e+00 | 0.000 | 1 | 1 |
| IRS-mediated signalling | R-HSA-112399 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.000000e+00 | 0.000 | 1 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 1.000000e+00 | 0.000 | 1 | 1 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 1.000000e+00 | 0.000 | 1 | 1 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.000000e+00 | 0.000 | 1 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.000000e+00 | 0.000 | 1 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.000000e+00 | 0.000 | 1 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 1.000000e+00 | 0.000 | 1 | 1 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 1.000000e+00 | 0.000 | 1 | 1 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.000000e+00 | 0.000 | 1 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.000000e+00 | 0.000 | 1 | 1 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 1.000000e+00 | 0.000 | 1 | 1 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.000000e+00 | 0.000 | 1 | 1 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.000000e+00 | 0.000 | 1 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
